|

Hepcidin and Glucose Metabolism

RECRUITINGN/ASponsored by Swiss Federal Institute of Technology
Actively Recruiting
PhaseN/A
SponsorSwiss Federal Institute of Technology
Started2019-07-03
Est. completion2025-12-31
Eligibility
Age18 Years – 45 Years
SexFEMALE
Healthy vol.Accepted

Summary

Gestational diabetes mellitus (GDM), defined as hyperglycemia with blood glucose values above normal but below those diagnostic of DM, and iron deficiency (ID) with or without anemia (IDA) are common during pregnancy. Both disease patterns are associated with an increased risk of complications during pregnancy and at delivery and may have a variety of negative effects on different aspects of child development. Thus, GDM and ID/IDA during pregnancy should be prevented. Whether iron supplementation with high oral doses acutely increases hepcidin during pregnancy, and whether this acute iron-induced increase in hepcidin decreases insulin sensitivity, is uncertain.

Eligibility

Age: 18 Years – 45 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* week of pregnancy 24-28
* pre-pregnancy BMI \<27.5kg/m2
* singleton pregnancy
* Hb \> 8.0 g/dl

Willing to either:

* not take any iron supplements for 14 days (however, participants will receive a similar amount of total iron during the 4 study days that they would normally receive over 14 days) OR
* to take the multivitamin "Burgerstein Schwangerschaft and Stillzeit" supplements over the 14 days (contains 30 mg iron)

Exclusion Criteria:

* iron infusion within the past 6 months
* severely anemic Hb\<8.0g/dl
* acute or chronic disease
* long-term medication
* medical problems known to affect iron homeostasis
* smoking

Conditions5

DiabetesGestational DiabetesGlucose IntoleranceIron Deficiency Anemia of PregnancyIron Metabolism Disorders

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.